CD8A and neoplasm: It is likely that these mechanisms are operating within the mesothelioma microenvironment and sabotage the ability of DCs to generate anti-mesothelioma immune responses, in particular the ability to stimulate tumor-specific CD8+ T cell proliferation in dLNs.